Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950142-22-000599
Filing Date
2022-02-11
Accepted
2022-02-11 15:13:35
Documents
1
Group Members
GAP (BERMUDA) L.P.GAP COINVESTMENTS CDA, L.P.GAP COINVESTMENTS III, LLCGAP COINVESTMENTS IV, LLCGAP COINVESTMENTS V, LLCGENERAL ATLANTIC (GK), L.P.GENERAL ATLANTIC (SPV) GP, LLCGENERAL ATLANTIC GENPAR (BERMUDA), L.P.GENERAL ATLANTIC GENPAR, L.P.GENERAL AT

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 eh220223340_13ga1-ginkgo.htm SC 13G/A 274068
  Complete submission text file 0000950142-22-000599.txt   276675
Mailing Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055
Business Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055 212 715 4000
GENERAL ATLANTIC, L.P. (Filed by) CIK: 0001017645 (see all company filings)

EIN.: 133503735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92710 | Film No.: 22620019
SIC: 2836 Biological Products, (No Diagnostic Substances)